New Zealand Society for the Study of Diabetes (NZSSD)
  • Home
  • NZSSD Executive
  • Membership
  • Health Professionals Section
  • DNSS Section
  • Position Statements
  • Press Releases
  • Awards and Grants
  • Meetings
  • Education
  • Newsletter
  • Related Websites
  • Disclaimer & Site Info
  • Site Map
  • Contact Us

Position Statements

Change to reporting of HbA1c – what is happening and why - July 2009

NZSSD Position Statement on standardisation of reporting units for HbA1c and application of estimated average glucose (eAG) - March 2009

NZSSD Executive Statement on Self Monitoring of Blood Glucose in non-insulin treated Type 2 Diabetes - February 2009

NZSSD Position Statement on Screening and Type 2 Diabetes - January 2009

NZSSD Position Statement on Insulin Pump Therapy - June 2008

NZSSD Executive Statement on Xenotransplantation in Type 1 Diabetes - June 2008

Royal College of Pathologists of Australia position statement on impaired fasting glucose (endorsed by NZSSD Executive) - February 2008

NZSSD Executive Statement on the use of HbA1c for diagnosis of diabetes - December 2007

Australian Diabetes Society position statement on Rosiglitazone (Avandia®) - May 2007

Management of Type 2 Diabetes - December 2003


© New Zealand Society for the Study of Diabetes (NZSSD)
Tel 64 3 470 3805
Fax 64 3 474 7641
Email
  • ^ Top of page
  • Home
  • Disclaimer & Site Info
  • Site Map
  • Contact Us

Page created: 17 December 2007
Page last modified: 23 February 2009